Insights

Loading spinner
Gathering insights about 4D Molecular Therapeutics

4D Molecular Therapeutics Tech Stack

4D Molecular Therapeutics uses 8 technology products and services including FactSet, oEmbed, jQuery Migrate, and more. Explore 4D Molecular Therapeutics's tech stack below.

  • FactSet
    Business Intelligence
  • oEmbed
    Dev Tools
  • jQuery Migrate
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • DocuSign
    Miscellaneous
  • Windows Server
    Operating Systems
  • Acquia Cloud Platform
    Platform As A Service
  • Paylocity
    Recruitment Marketing

Media & News

4D Molecular Therapeutics's Email Address Formats

4D Molecular Therapeutics uses at least 1 format(s):
4D Molecular Therapeutics Email FormatsExamplePercentage
FLast@4dmoleculartherapeutics.comJDoe@4dmoleculartherapeutics.com
83%
First.Last@4dmoleculartherapeutics.comJohn.Doe@4dmoleculartherapeutics.com
15%
Last.First@4dmoleculartherapeutics.comDoe.John@4dmoleculartherapeutics.com
2%

Frequently Asked Questions

Where is 4D Molecular Therapeutics's headquarters located?

Minus sign iconPlus sign icon
4D Molecular Therapeutics's main headquarters is located at 5858 Horton St, 455 Emeryville, California 94608, US. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is 4D Molecular Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact 4D Molecular Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is 4D Molecular Therapeutics's stock symbol?

Minus sign iconPlus sign icon
4D Molecular Therapeutics is a publicly traded company; the company's stock symbol is FDMT.

What is 4D Molecular Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
4D Molecular Therapeutics's official website is 4dmoleculartherapeutics.com and has social profiles on LinkedInCrunchbase.

What is 4D Molecular Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
4D Molecular Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does 4D Molecular Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2025, 4D Molecular Therapeutics has approximately 221 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Commercial Officer: C. S.Vice President Of Business Development: D. B.Vice President Clinical Development: L. K.. Explore 4D Molecular Therapeutics's employee directory with LeadIQ.

What industry does 4D Molecular Therapeutics belong to?

Minus sign iconPlus sign icon
4D Molecular Therapeutics operates in the Biotechnology Research industry.

What technology does 4D Molecular Therapeutics use?

Minus sign iconPlus sign icon
4D Molecular Therapeutics's tech stack includes FactSetoEmbedjQuery MigratejQueryDocuSignWindows ServerAcquia Cloud PlatformPaylocity.

What is 4D Molecular Therapeutics's email format?

Minus sign iconPlus sign icon
4D Molecular Therapeutics's email format typically follows the pattern of FLast@4dmoleculartherapeutics.com. Find more 4D Molecular Therapeutics email formats with LeadIQ.

How much funding has 4D Molecular Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2025, 4D Molecular Therapeutics has raised $268M in funding. The last funding round occurred on Jan 01, 2020 for $75M.

When was 4D Molecular Therapeutics founded?

Minus sign iconPlus sign icon
4D Molecular Therapeutics was founded in 2013.
4D Molecular Therapeutics

4D Molecular Therapeutics

Biotechnology ResearchUnited States201-500 Employees

4DMT is a clinical stage biopharma company inventing and developing innovative products to unlock the full potential of genetic medicine to treat large market and rare diseases. Our vector discovery platform Therapeutic Vector Evolution harnesses the power of directed evolution, a Nobel Prize-winning technology, with approximately one billion synthetic AAV capsid-derived sequences to invent customized and evolved vectors with improved therapeutic profiles compared to wild-type vectors. Our product design, development and manufacturing engine empowers us to efficiently create our valuable and diverse product pipeline. This combination of bold innovation and relentless execution gives 4DMT the capability to revolutionize genetic medicines and to strive for potential curative therapies. We have built a deep portfolio of genetic medicine product candidates, with five product candidates in clinical trials for seven patient populations.

We are taking genetic medicine to new heights and into new disease areas to overcome challenges not addressed by existing medicines. This incredible challenge drives our relentless and talented team. Our people are the essence of our inspiring, innovative and collaborative environment that encourages individual contributions and provides opportunities for career development. We seek the best in the industry who identify with our mission and our bold and innovative results-driven approach. Our 4 Guiding Principles drive the way we work together: 
-	Dare to Cure
-	Break Boundaries 
-	Beyond Yourself 
-	Prepare & Execute Relentlessly 

Join us in creating the future of genetic medicine.

Section iconCompany Overview

Headquarters
5858 Horton St, 455 Emeryville, California 94608, US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
FDMT
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
201-500

Section iconFunding & Financials

  • $268M

    4D Molecular Therapeutics has raised a total of $268M of funding over 4 rounds. Their latest funding round was raised on Jan 01, 2020 in the amount of $75Mas a Series C.

  • $10M$25M

    4D Molecular Therapeutics's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $268M

    4D Molecular Therapeutics has raised a total of $268M of funding over 4 rounds. Their latest funding round was raised on Jan 01, 2020 in the amount of $75Mas a Series C.

  • $10M$25M

    4D Molecular Therapeutics's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.